SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Papa John's International, Inc. engages in the operation and franchise of pizza delivery and carryout restaurants. It operates through the following segments: Domestic Company-owned Restaurants, North America Franchising, North America Commissaries, International Operations, and All Others. The Domestic Company-Owned Restaurants segment consists of retail sales of pizza and side items, breadsticks, cheese sticks, chicken poppers and wings, dessert items, and canned and bottled beverages. The North America Franchising segment involves the offering of sales and support activities, development rights, and collection of royalties from franchisees located in the United States and Canada. The North America Commissaries segment includes the eleven full-service regional dough production and distribution and quality control centers. The International Operations segment represents all restaurant operations outside of the United States and Canada. The All Others segment focuses on franchise contributions to marketing funds and sale, company-owned and franchised restaurants, information systems and related services used in restaurant operations, point-of-sale system, online and other technology-based ordering platforms, printing, and promotional items. The company was founded by John H. Schnatter in 1984 and is headquartered in Louisville, KY.

Papa John`s International, Inc.

Attention is centered on reports that Papa Johns largest U.S. franchisee has joined Irth Capitals effort to take the company private, reviving buyout hopes. Traders see the franchisees involvement as strengthening the proposal, while others remain skeptical that the board will approve a deal or that negotiations will produce a signed transaction.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Phase 3 results for Amgens IMDELLTRA-plus-IMFINZI combination in extensive-stage small-cell lung cancerreported to reduce the risk of death by 58%are driving discussion, with traders viewing the data as a potential growth opportunity. Some also point to Repathas sales growth as a key business driver and debate whether the lung-cancer program can become a major contributor.

TOSHI

TOSHI is drawing attention around a hoped-for breakout after bursts of volume and a modest rebound, with traders repeatedly watching a stubborn resistance zone and speculating about a short squeeze. Bulls are accumulating and anticipating a run, while skeptics point to repeated rejections, weak price action, and broader crypto-market risk; rumors of listings or an announcement remain unconfirmed.

Palo Alto Networks, is a cybersecurity company that provides cybersecurity platforms and services to enterprises, organizations, service providers, and government entities. Its offerings include network and AI security, cloud security, security operations, and identity security solutions. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks rallied with cybersecurity peers as traders focused on an Evercore ISI survey indicating enterprise security budgets are firming and on escalating vulnerability and AI-driven cyberthreat concerns. The move drew bullish momentum commentary, while some traders questioned whether the sectors gains are justified given lofty valuations.

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.

Celcuity Inc

Updated ESMO subgroup analyses from Celcuitys Phase 3 VIKTORIA-1 breast-cancer study are driving discussion, with traders highlighting favorable efficacy for gedatolisib and the potential for a PIK3CA-mutant label expansion. The reaction is split between enthusiasm for the data and concern that CELC still needs to demonstrate commercial uptake and revenue; some posts also debate whether the share price reflects the clinical results.

iShares Trust - iShares Biotechnology ETF

iShares Biotechnology ETF

A broad biotech-sector pullback is the main focus, with IBB hovering near its 50-day moving average after a strong run. Traders describe the dip as a pause while others remain cautious about sector weakness, and several note that large-cap biotech is holding up better than smaller names.

Cloudflare, Inc. engages in the provision of cloud-based services to secure websites. The firm offers various products for application security, performance and reliability, network services, Zero Trust, developer platform, media delivery, insights, domain registration, and consumer services. It operates through the United States and Rest of the World geographical segments. The company was founded by Matthew Prince, Michelle Zatlyn, and Lee Holloway in July 2009 and is headquartered in San Francisco, CA.

Cloudflare Inc - Ordinary Shares - Class A

Cloudflare Inc

Cloudflare shares are drawing attention after a sharp gain tied to the PHP2Shell web-software vulnerabilities: traders see its web application firewall as a potential beneficiary as site operators seek protection, alongside a broader cybersecurity-stock rally. Some participants are bullish on the security-demand angle, while others focus on the stocks high valuation and trade the move cautiously.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Attention centers on Merck and Modernas Phase 3 melanoma-vaccine results: the personalized vaccine combined with Keytruda met trial endpoints, but traders debate whether the benefit and future commercial potential justify expectations, with some viewing the share pullback as a sell the news reaction. The treatment is not yet approved, and its broader use remains uncertain.

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

BioNTech SE - ADR

Promising lung-cancer trial updates for BioNTechs oncology pipeline, including pumitamig and gotistobart, are drawing attention, with traders highlighting encouraging response and survival data. The reaction is bullish but tempered by questions about how durable the results are and lingering concerns over earlier clinical setbacks and leadership changes.

The GEO Group, Inc. engages in the design, financing, development, and support services for secure facilities, processing centers, and community re-entry facilities. It operates through the following segments: U.S. Secure, Electronic Monitoring and Supervision, Reentry, and International Services. The U.S. Secure Services segment encompasses the United States-based public-private partnership corrections and detention business. The Electronic Monitoring and Supervision Services segment conducts its services in the U.S. The Reentry Services Segment consists of various community-based and reentry services. The International Services segment consists of public-private partnership secure services operations in Australia and South Africa. The company was founded by George C. Zoley in 1984 and is headquartered in Boca Raton, FL.

Geo Group, Inc.

GEOs sale of its Adelanto facilities to DHS and the resulting debt-reduction and buyback flexibility are driving discussion. Traders see the transaction as a balance-sheet positive, while others question the stocks weakness and weigh the benefits against giving up ownership economics; many are looking for clarity on further sales.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The Zacks Analyst Blog XLEI,WEEI,MDST,AMZA and EIPI

XLEI leads a pack of high-yield energy ETFs as oil volatility and Middle East tensions keep income-focused funds in the spotlight.

Buy 5 Energy ETFs With At Least 5% Yield 

Energy ETFs are likely to remain strong, as oil prices are unlikely to return to pre-war levels even if an Iran war truce materializes, keeping high-yield funds in focus.

Shell Stock In Focus After Landmark Climate Ruling, Retail’s Upbeat

Equity

Retail sentiment on the stock turned ‘bullish’ (67/100) from ‘bearish’ (43/100) a day ago.

First Trust Exchange-Traded Fund VIII - FT Energy Income Partners Enhanced Income ETF

Neutral Sentiment

Oil and gas major Shell’s ($SHEL) ADR shares were down over 2% on Tuesday morning after a landmark court ruling in Hague overturned a previous verdict requiring the oil giant to cut harmful emissions contributing to global warming. Retail investors on Stocktwits took a more favorable view of the decision.On Tuesday, the Hague Court of Appeal reaffirmed Shell’s responsibility towards addressing climate change, but ruled the company couldn’t be directed to cut specific emissions, according to several news reports.The decision is <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.belganewsagency.eu/dutch-court-overturns-climate-verdict-against-oil-company-shell">seen </a>as a setback for climate action, particularly Shell’s and other oil majors’ role in cutting carbon emissions. Shell had to cut emissions by 45% by 2030 from 2019 levels, as mandated by the earlier ruling dating back to 2021. That <a target="_blank" rel="noopener noreferrer nofollow" href="https://edition.cnn.com/2024/11/12/energy/shell-climate-case-netherlands/index.html">ruling</a>, which the company appealed against, included all CO2 emissions from Shell’s own production as well as any third party products.“We are pleased with the court’s decision, which we believe is the right one for the global energy transition, the Netherlands and our company,” Shell CEO Wael Sawan was quoted as saying by Reuters.Retail sentiment on the stock turned ‘bullish’ (67/100) from ‘bearish’ (43/100) a day ago. Message volumes were in the normal range.<figure class="image"><img style="aspect-ratio:1300/290;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_11_12_at_7_55_33_PM_cd391a356d.png" alt="Screenshot 2024-11-12 at 7.55.33 PM.png" width="1300" height="290"><figcaption>SHEL sentiment meter and message volumes on Nov 12 as of 9:20 am ET</figcaption></figure>The landmark ruling comes at a time when the COP29 UN climate summit has just commenced in Baku, Azerbaijan. COP29’s opening day proceedings were also <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/sustainability/cop/eus-von-der-leyen-skip-cop29-climate-summit-2024-11-05/">reportedly </a>held up by a dispute over the role fossil fuels would have on the summit’s agenda.The Director of the Dutch arm of environmental group Friends of the Earth, Donald Pols, was quoted as saying, "This hurts…At the same time, this case has shown that large polluters are not above the law." Friends of The Earth originally challenged the oil major, approaching the courts to make the oil company take strong steps towards preventing global warming.Meanwhile, Shell is said to be investing $10 to $15 billion between 2023 and 2025 in low-carbon energy projects, according to the Reuters report, which noted the company’s decision to cut back on its renewable efforts because of the time it takes to generate profit.In Shell’s favor were court observations agreeing with the company’s argument that “an absolute order” to reduce its Scope 3 emissions could have an adverse effect, turning customers to the more polluting coal.Shell stock is up 3% year-to-date.For updates and corrections, email newsroom@stocktwits.com.&nbsp;

The decision is seen as a setback for climate action, particularly Shell’s and other oil majors’ role in cutting CO2.| Source: Pixabay

Shell Plc - ADR (Representing - Ordinary Shares)

SPDR Portfolio Developed World ex-US ETF

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$22.59
Prev Close	$22.35
Open	$22.24
Dividend Yield	N/A
50-Day Moving Average	$22.33
Beta	N/A
Avg. Volume	71,125.46
PE Ratio	N/A

52-Week High	$23.08
52-Week Low	$19.37
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

EIPI Fundamentals